Related Experiment Video
Updated: Aug 4, 2026
06:55
Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
Published on: May 11, 2014
Prevalence of short-segment Barrett's epithelium
Z Fireman1, G Wagner, J Weissman
1Department of Gastroenterology, Hillel Yaffe Medical Center, Hadera, Israel. fireman@hillel-yaffe.health.gov.il
Summary
Routine biopsies detected intestinal metaplasia in 8% of patients, lower than literature rates. Alcian blue staining improved detection of short segment Barrett's esophagus, highlighting its value in identifying this esophageal adenocarcinoma risk factor.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Esophageal adenocarcinoma incidence is rising, with Barrett's epithelium as a key risk factor.
- Barrett's epithelium is characterized by intestinal metaplasia, often overlooked in short segments.
- Routine biopsies of distal esophagus mucosa show variable rates (up to 36%) of short segment Barrett's epithelium.
Purpose of the Study:
- To compare the prevalence of intestinal metaplasia in routine biopsies from a community hospital in Israel.
- To evaluate the diagnostic yield of routine biopsies for detecting short segment Barrett's epithelium.
Main Methods:
- 112 consecutive patients undergoing esophagogastroduodenoscopy were enrolled.
- Biopsy specimens were taken from the cardia, gastroesophageal junction, and 2 cm above.
- Specimens were stained with hematoxylin & eosin and Alcian blue.
Main Results:
- A prevalence of 8.04% for intestinal metaplasia was found.
- Six patients (6.66%) with intestinal metaplasia had normal-appearing mucosa.
- Alcian blue staining identified 2 additional cases missed by hematoxylin & eosin.
Conclusions:
- The study found an 8% prevalence of intestinal metaplasia, lower than reported literature values.
- Routine biopsies provided an added diagnostic advantage of 5.4% for detecting intestinal metaplasia.
- Alcian blue staining enhances the detection of intestinal metaplasia in routine biopsies.
Related Concept Videos
01:25Mucosal Barrier of the Stomach
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
01:21Barrett Esophagus-I: Introduction
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
01:21Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
01:30Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...